House Dems In New Seats Of Power Will Steer Health Policy, Attack Drug Prices
Democrats, who have a history of championing the Affordable Care Act and railing about drug prices, will now chair several house committees.
Showing 61 - 76 of 76
-
-
In Swing Districts, Republicans May Pay For Having Tried To Reverse The Health Law
Though Rep. Tom MacArthur (R-N.J.) counts himself a moderate, many of his voters heading to the polls are furious about how he aided his party’s efforts to dismantle Obamacare.
-
Drugmakers Funnel Millions To Lawmakers; A Few Dozen Get $100,000-Plus
Drugmakers' contributions to lawmakers have peaked as surging drug prices emerge as a hot-button political issue. In the past decade, Congress has received nearly $79 million from 68 pharma PACs, run by employees of companies that make drugs treating everything from cancer to erectile dysfunction.
By Emmarie Huetteman and Sydney Lupkin -
The Feds’ Termination Of A Tiny Contract Inflames Bitter Fight Over Fetal Tissue
Just weeks before midterm elections, a move by federal health officials spotlights a contentious issue: the use of human fetal tissue in research. Here’s what you need to know to understand the debate.
-
Threat To The ACA Turns Up The Heat On Attorney General Races
As Republican and Democratic attorneys general square off on a Texas case that threatens to dismantle consumer protections in the federal health law, campaigns across the country for states’ highest legal officer get hotter.
-
Wisconsin Reinstates Coverage Of Transgender Treatment For State Workers
The Group Insurance Board reversed a decision made last year to bar coverage of transgender hormone therapy and surgery for public workers.
-
McCain’s Complicated Health Care Legacy: He Hated the ACA. He Also Saved It.
The six-term Arizona senator, who died Saturday, took on some of health care’s goliaths, such as the tobacco industry and insurance companies, in addition to the health law.
-
A Transgender Woman’s Quest For Surgery Caught In Political Crosswinds
Dramatic policy swings, from an unprecedented expansion of transgender rights under the Obama administration to the unpredictable reduction of trans rights under President Donald Trump, have left many trans Americans feeling the whiplash.
-
A Transgender Woman’s ‘Bait-And-Switch’ $92,000 Surgery Bill
After being promised a significant discount for paying cash upfront and forgoing insurance, a Wisconsin patient gets caught in the middle between hospital and insurer — and feels snookered by a last-minute surprise and billing snafu.
-
Unwieldy Health Costs Often Stand Between Teachers And Fatter Paychecks
Cash-strapped school boards, cities and legislatures scrounge to cover pay raises and pricey benefits and turn to teachers to fork over more of their shrinking take-home pay.
-
Postcard From D.C.: Kicking Around The ACA? For Tom Price, That’s So 2017.
The former secretary of the Department of Health and Human Services says the law eliminating penalties for most people who don’t have insurance coverage will hurt the insurance marketplaces.
-
Make Room For Baby: After Giving Birth, Duckworth Presses Senate To Bend Rules
The Illinois Democrat is the first sitting senator to give birth. She’s using the opportunity to call for adjusting Senate rules to accommodate new parents.
-
At New Health Office, ‘Civil Rights’ Means Doctors’ Right To Say No To Patients
The HHS civil rights division refocuses on the rights of health care providers who have moral objections to treatments such as abortion or sterilization, alarming critics.
-
Opioid Crisis Hits Home: Uncle’s Overdose Spurs Medicaid Official To Change Course
Andrey Ostrovsky, who until last month was chief medical officer for Medicaid, quit his job so he could more directly fight the stigma of drug addiction.
-
With CHIP Funds Running Low, Doctors And Parents Scramble To Cover Kids’ Needs
Doctors are advising patients to be sure to fill medication orders now or are giving away drugs to make sure children have enough if their insurance disappears.
By Phil Galewitz and Emmarie Huetteman -
HHS Nominee Vows To Tackle High Drug Costs, Despite His Ties To Industry
Alex M. Azar II, the former president of the U.S. division of Eli Lilly, says the U.S. drug system encourages price increases — but he intends to work on that problem.
Sign Up For Our Newsletter
Stay informed by signing up for the Morning Briefing and other emails: